SRE Holdings (2980) Q2 2027 earnings summary

Executive summary

• Six-month net sales rose 69.3% YoY to ¥13,708 million and operating profit increased 530.1% to ¥1,948 million, driven by property sales and recurring AI & Life Solutions revenue.

• Growth strategy focuses on industry-specific AI and BPaaS, healthcare coverage and operational support to expand recurring revenue.

Financial highlights

• Net sales were ¥13,708 million, operating profit ¥1,948 million and ordinary profit ¥1,674 million; ordinary profit rose from ¥185 million a year earlier.

• Profit attributable to owners of parent was ¥1,055 million versus ¥26 million; EBITDA was ¥2,322 million, up 239.7% YoY.

• Gross profit was ¥5,709 million versus ¥3,495 million; SG&A was ¥3,761 million versus ¥3,186 million.

Outlook and guidance

• FY2027 forecast remains unchanged: net sales ¥41,800 million (+27.2%), operating profit ¥5,230 million (+25.1%), ordinary profit ¥4,500 million (+17.2%) and parent-attributable profit ¥2,830 million (+53.8%).

• Underlying operating profit growth is forecast at 38%, excluding ¥0.4 billion of strategic reinvestment and a ¥0.15 billion risk buffer; delayed investment or unrealized risks could create short-term upside.

• Annual dividend forecast remains ¥20 per share; basic EPS forecast is ¥175.60.

• Property development and leasing are progressing toward second-half sales; segment earnings vary with the timing of self-developed property sales.